Surgery Partners, Inc. SGRY
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- +50.23%
- 1 year
- +4.74%
- Open
- 23.24
- Prev close
- 23.21
- Mkt cap
- 2.99B
- Vol
- 3.51M
- Avg vol
- 3.33M
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.19
- High
- 23.25
- Forward P/E
- 111.43
- Beta
- 1.91
- Short ratio
- 6.88
- Inst. own
- 128.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 14.95
- 200-d avg
- 14.59
- 1y target
- 21.70
5D chart
Events in this range
- Oct 27, 2026Downgrade: StoneX · Buy → Hold
- Oct 28, 2026Downgrade: UBS · Buy → Neutral
Signals (51)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 10:25 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:35 AM | 2 days ago |
| RSI: Overbought | Oct 29, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:20 PM | 3 days ago |
| RSI: Oversold | Oct 29, 11:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:45 PM | 4 days ago |
| RSI: Oversold | Oct 28, 1:05 PM | 4 days ago |
| RSI: Oversold | Oct 28, 12:50 PM | 4 days ago |
| RSI: Oversold | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 5 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| RSI: Overbought | Oct 27, 3:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:15 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:00 PM | 6 days ago |
| RSI: Overbought | Oct 26, 1:10 PM | 6 days ago |
| RSI: Overbought | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:15 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 6 days ago |
News
2 days ago globenewswire.com
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares
NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ:…
3 days ago newsfilecorp.com
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger
BFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest…
-
4 days ago benzinga.com
UBS Downgrades Surgery Partners to Neutral, Raises Price Target to $23.5
UBS analyst A.J. Rice downgrades Surgery Partners (NASDAQ:SGRY) from Buy to Neutral and raises the price target from $21 to $23.5.
4 days ago prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Surgery Partners, Inc. (NASDAQ: SGRY)
NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
5 days ago businesswire.com
Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of…
5 days ago businesswire.com
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
NEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law.
6 days ago gurufocus.com
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
6 days ago businesswire.com
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $SGRY--SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law.
6 days ago fool.com
Stock Market Today, Oct. 26: AI Optimism Lifts Nasdaq as Tech Stocks Rebound
On Oct. 26, 2026, Anthropic's IPO filing sparked a tech rally, while Meta's $95 billion AI infrastructure plan weighed on sentiment.
6 days ago fool.com
Stock Market Today, Oct. 26: Surgery Partners Skyrockets 48% on $5.7 Billion HealthSpan Acquisition
NASDAQ · As of 4:00 PM ET 10/26/26
6 days ago prnewswire.com
SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC.
SGRY shareholders will receive just $23.50 per share in an all-cash transaction valued at approximately $5.7 billion in enterprise value; Ademi LLP is investigating the deal price, benefits to…
6 days ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Surgery Partners (NASDAQ:SGRY) shares moved upwards by 46.9% to $23.14 during Monday's regular session. The market value of their outstanding shares is at $2.0 billion. SciSparc (NASDAQ:SPRC)…
6 days ago benzinga.com
Surgery Partners Surges as $5.7 Billion Deal Takes Company Private
The Surgery Partners deal values the company at $5.7 billion, offering public shareholders $23.50 per share in cash.
6 days ago wsj.com
Bon Secours Affiliate to Acquire Surgery Partners in $5.7 Billion Take-Private Deal
Bain Capital-backed Surgery Partners operates through a network of ambulatory surgery centers, surgical hospitals and physician partnerships.
6 days ago benzinga.com
Crude Oil Edges Lower; Chicago Fed Activity Index Rises In September
U.S. stocks climbed Monday: Nasdaq +0.99%, S&P 500 +0.75%, led by tech; Surgery Partners and Xtend AI surged, while Brazil-linked stocks fell.
6 days ago gurufocus.com
SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Surgery Partners, Inc. (NASDAQ: SGRY) to HealthSpan Partners for $23.50 in cash per
6 days ago benzinga.com
Range Resources, Xtend AI Robotics, Oruka Therapeutics And Other Big Stocks Moving Higher On Monday
U.S. stocks rose; Dow gained 350 points. Range Resources jumped 15% on EQT acquisition, while Surgery Partners and others posted sharp gains.
6 days ago businesswire.com
SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Surgery Partners, Inc. (NASDAQ: SGRY) to HealthSpan Partners for $23.50 in cash per share.Halper…
-
6 days ago benzinga.com
HealthSpan Partners Agrees To Acquire Surgery Partners For ~$5.7B In Cash
HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health ("BSMH"), and Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical…
6 days ago businesswire.com
HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform
CINCINNATI & BRENTWOOD, Tenn.--(BUSINESS WIRE)--HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc.…
6 days ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
6 days ago benzinga.com
Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Surgery Partners Inc (NASDAQ:SGRY) rose sharply in pre-market trading after the Financial Times reported that Bon Secours Mercy Health is in late-stage talks to acquire a majority stake in…
6 days ago benzinga.com
Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Surgery Partners surged 20.6% on reported $6B Bon Secours deal talks; Scisparc and Xencor led gainers, while XP and others plunged.
2 weeks ago gurufocus.com
Larry Robbins Opens New Position in Surgery Partners Inc (SGRY) -- Shares Look 39% Undervalued on GF Value
On October 6, 2026, Larry Robbins (Trades, Portfolio) of Glenview Capital Management initiated a new position in Surgery Partners Inc (SGRY), acquiring 7,023,33
-
1 month ago benzinga.com
RBC Capital Reiterates Outperform on Surgery Partners, Maintains $19 Price Target
RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $19 price target.
1 month ago zacks.com
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price…
1 month ago seekingalpha.com
Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment
I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from…
-
1 month ago benzinga.com
TD Cowen Reiterates Buy on Surgery Partners, Maintains $19 Price Target
TD Cowen analyst Ryan Langston reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $19 price target.
1 month ago globenewswire.com
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today…
1 month ago benzinga.com
Meta Platforms To $650? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised price targets for Meta, IREN, Coinbase, Roblox and others; IREN and Coinbase were upgraded, while other ratings held steady.
-
1 month ago benzinga.com
JP Morgan Maintains Neutral on Surgery Partners, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $14 to $15.
1 month ago fool.com
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.
-
2 months ago benzinga.com
TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $17 to $19.
-
2 months ago benzinga.com
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19
RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $20 to $19.
-
2 months ago benzinga.com
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $18 price target.
-
2 months ago benzinga.com
Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 66.67 percent. This is a 41.18 percent decrease over earnings of…
-
2 months ago benzinga.com
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
3 months ago benzinga.com
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
Surgery Partners rises after agreeing to sell Idaho Falls hospital stakes for $795 million while reaffirming its 2026 outlook
-
3 months ago benzinga.com
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
-
3 months ago benzinga.com
Surgery Partners To Sell Ownership Interests In Mountain View Hospital And Idaho Falls Community Hospital To Intermountain Health; Deal Values Combined Idaho Falls Facilities At ~$1.15B, Total Consideration To Surgery Partners ~$795M
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced it, along with its existing partner Intermountain
6 months ago benzinga.com
Surgery Partners Q1 2026 Earnings Call Transcript
Surgery Partners Q1 2026 Earnings Call Transcript
-
6 months ago benzinga.com
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est
2026 GuidanceFull year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million
-
6 months ago benzinga.com
Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) by 75 percent. This is a 175 percent decrease over earnings of $0.04…
-
7 months ago benzinga.com
Ortelius Urges Surgery Partners Overhaul After Underperformance, Calls For Hospital Divestitures, Board Refresh, And Management Change
Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held AccountableLetter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for…
-
8 months ago benzinga.com
TD Cowen Maintains Buy on Surgery Partners, Lowers Price Target to $20
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $28 to $20.
8 months ago benzinga.com
Analyst Expectations For Surgery Partners's Future
Analyst Expectations For Surgery Partners's Future
-
8 months ago benzinga.com
UBS Maintains Buy on Surgery Partners, Lowers Price Target to $21
UBS analyst A.J. Rice maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $29 to $21.
-
8 months ago benzinga.com
Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $17
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $19 to $17.
-
8 months ago benzinga.com
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $20
RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $31 to $20.